U.S. flag

An official website of the United States government

NM_001360016.2(G6PD):c.1004C>A (p.Ala335Asp) AND Anemia, nonspherocytic hemolytic, due to G6PD deficiency

Germline classification:
Pathogenic/Likely pathogenic (2 submissions)
Last evaluated:
Aug 12, 2022
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001379702.8

Allele description [Variation Report for NM_001360016.2(G6PD):c.1004C>A (p.Ala335Asp)]

NM_001360016.2(G6PD):c.1004C>A (p.Ala335Asp)

Gene:
G6PD:glucose-6-phosphate dehydrogenase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
Xq28
Genomic location:
Preferred name:
NM_001360016.2(G6PD):c.1004C>A (p.Ala335Asp)
Other names:
G6PD Fushan
HGVS:
  • NC_000023.11:g.154532989G>T
  • NG_009015.2:g.19584C>A
  • NM_000402.4:c.1094C>A
  • NM_001042351.3:c.1004C>A
  • NM_001360016.2:c.1004C>AMANE SELECT
  • NP_000393.4:p.Ala365Asp
  • NP_001035810.1:p.Ala335Asp
  • NP_001346945.1:p.Ala335Asp
  • NC_000023.10:g.153761204G>T
  • NM_001042351.1:c.1004C>A
Protein change:
A335D
Links:
dbSNP: rs1557229854
NCBI 1000 Genomes Browser:
rs1557229854
Molecular consequence:
  • NM_000402.4:c.1094C>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001042351.3:c.1004C>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001360016.2:c.1004C>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Anemia, nonspherocytic hemolytic, due to G6PD deficiency
Synonyms:
Hemolytic anemia due to G6PD deficiency; Favism, susceptibility to; Class I glucose-6-phosphate dehydrogenase deficiency
Identifiers:
MONDO: MONDO:0010480; MedGen: C2720289; Orphanet: 466026; OMIM: 300908

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001577550Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Likely pathogenic
(Mar 29, 2020)
germlineclinical testing

PubMed (11)
[See all records that cite these PMIDs]

SCV002599354Dunham Lab, University of Washington
criteria provided, single submitter

(Bayesian ACMG Guidelines, 2018)
Pathogenic
(Aug 12, 2022)
unknowncuration

PubMed (6)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedunknownyesnot providednot providednot providednot providednot providedcuration

Citations

PubMed

Distribution of glucose-6-phosphate dehydrogenase mutations in Southeast Asia.

Iwai K, Hirono A, Matsuoka H, Kawamoto F, Horie T, Lin K, Tantular IS, Dachlan YP, Notopuro H, Hidayah NI, Salim AM, Fujii H, Miwa S, Ishii A.

Hum Genet. 2001 Jun;108(6):445-9.

PubMed [citation]
PMID:
11499668

Further investigations of glucose-6-phosphate dehydrogenase variants in Flores Island, eastern Indonesia.

Kawamoto F, Matsuoka H, Kanbe T, Tantular IS, Pusarawati S, Kerong HI, Damianus W, Mere D, Dachlan YP.

J Hum Genet. 2006;51(11):952-957. doi: 10.1007/s10038-006-0044-y. Epub 2006 Aug 23.

PubMed [citation]
PMID:
16927025
See all PubMed Citations (15)

Details of each submission

From Invitae, SCV001577550.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (11)

Description

In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant disrupts the p.Ala335 amino acid residue in G6PD. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 11499668, 16927025, 20602793, 21677401, 22293322, 25548459, 2606066). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). This variant has been observed in individual(s) with glucose-6-phosphate dehydrogenase deficiency (PMID: 5775246, 15625830, 7803800). This variant is not present in population databases (ExAC no frequency). This sequence change replaces alanine with aspartic acid at codon 335 of the G6PD protein (p.Ala335Asp). The alanine residue is moderately conserved and there is a moderate physicochemical difference between alanine and aspartic acid.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Dunham Lab, University of Washington, SCV002599354.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcuration PubMed (6)

Description

Variant found in unrelated hemizygotes with deficiency, some with anemia (PS4_M, PP4). Decreased activity in red blood cells (11-19%) (PS3). Affects same amino acid as pathogenic 335A>T (ClinVar ID 10363) (PM5). Below expected carrier frequency in gnomAD (PM2). Post_P 0.997 (odds of pathogenicity 3158, Prior_P 0.1).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Mar 30, 2024